Advanced Cell Technology to Host Conference Call to Provide a Corporate Update
April 01 2014 - 4:38PM
Business Wire
Webcast Scheduled for Thursday, April 3 at
8:30 a.m. Eastern Time
Advanced Cell Technology, Inc. (“ACT”; OTCBB:ACTC), a
leader in the field of regenerative medicine, announced today that
it filed its annual report on Form 10-K for the year ended December
31, 2013. The Company will host a conference call on Thursday,
April 3, 2014, at 8:30 a.m. EDT during which it will provide a
corporate update.
Interested parties may access the call live by dialing (888)
264-3177 and using conference ID 87114671. This event is
also being streamed via webcast. The webcast is available
at http://engage.vevent.com/rt/act~advancedcelltechnology040314
. A replay of the call will also be available via the same
link.
About Advanced Cell Technology, Inc.
Advanced Cell Technology, Inc. is a Marlborough, Mass.-based
biotechnology company focused on the development and
commercialization of human embryonic stem cell (hESC) and adult
stem cell technology. The company’s most advanced products are in
clinical trials for the treatment of dry age-related macular
degeneration and Stargardt’s macular degeneration. ACT’s
preclinical programs involve cell therapies for the treatment of
other ocular disorders and for diseases outside the field of
ophthalmology, including autoimmune, inflammatory and wound
healing-related disorders. The company’s intellectual property
portfolio includes pluripotent stem cell platforms – hESC and
induced pluripotent stem cell (iPSC) – and other cell therapy
research programs. For more information,
http://www.advancedcell.com or connect with the Company on
Facebook, Twitter, LinkedIn, Google+, and YouTube.
Investors:CEOcast, Inc.Bob Woods, 212-732-4300orPress:Russo
PartnersDavid Schull, 858-717-2310